---
figid: PMC3684083__nihms459788f2
figtitle: 'EGFR/TGFA and TGFB/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical
  Therapeutic Targets'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- clinical samples
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC3684083
filename: nihms459788f2.jpg
figlink: /pmc/articles/PMC3684083/figure/F2/
number: F2
caption: 'Under physiological conditions, activation of TGFβR complex I and II following
  TGFβ binding results in G1 cell cycle arrest (through the inhibitory activity of
  P21WAF1/CIP1) (central panel). These effects are mediated via the serine threonine
  kinase of the receptor complex, SMAD2,3,4 activation (through phosphorylation) and
  nuclear targeting of these transcription factors. BMP receptors are also associated
  with activation of the SMAD cascade. In NENs (and other tumors e.g., glioblastomas),
  nuclear targeting of SMAD is inhibited and cross-activation of growth-stimulatory
  pathways occur including the RAS/RAF/MAPK signaling pathway and the PI3K/AKT/mTOR
  pathways. Under these circumstances, TGFβ switches to a pro-proliferative role.
  No preclinical or clinical studies have been conducted using TGFβRI inhibitors in
  NENs, while other studies have demonstrated the utility of targeting the mTOR pathway.
  Solid lines: good evidence for pathway activation; dotted lines: incomplete evidence.'
papertitle: 'EGFR/TGFα and TGFβ/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical
  Therapeutic Targets.'
reftext: M. Kidd, et al. Neuroendocrinology. ;97(1):35-44.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9578574
figid_alias: PMC3684083__F2
figtype: Figure
redirect_from: /figures/PMC3684083__F2
ndex: 13f6f454-dee5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3684083__nihms459788f2.html
  '@type': Dataset
  description: 'Under physiological conditions, activation of TGFβR complex I and
    II following TGFβ binding results in G1 cell cycle arrest (through the inhibitory
    activity of P21WAF1/CIP1) (central panel). These effects are mediated via the
    serine threonine kinase of the receptor complex, SMAD2,3,4 activation (through
    phosphorylation) and nuclear targeting of these transcription factors. BMP receptors
    are also associated with activation of the SMAD cascade. In NENs (and other tumors
    e.g., glioblastomas), nuclear targeting of SMAD is inhibited and cross-activation
    of growth-stimulatory pathways occur including the RAS/RAF/MAPK signaling pathway
    and the PI3K/AKT/mTOR pathways. Under these circumstances, TGFβ switches to a
    pro-proliferative role. No preclinical or clinical studies have been conducted
    using TGFβRI inhibitors in NENs, while other studies have demonstrated the utility
    of targeting the mTOR pathway. Solid lines: good evidence for pathway activation;
    dotted lines: incomplete evidence.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tgfb1
  - Ltbp1
  - Bmp2
  - Bmpr2
  - Tgfbr1
  - Tgfbr2
  - Pik3r1
  - ras
  - Hras
  - Kras
  - Rem1
  - Braf
  - Braf-rs1
  - Smad2
  - Akt1
  - Smad3
  - Smad4
  - Mdk
  - Mtor
  - Ephb2
  - Mapk1
  - Cdkn1a
  - Slc12a9
  - Pik3cg
  - Ephb1
  - TGFB1
  - TGFB2
  - TGFB3
  - BMP2
  - TGFBR1
  - TGFBR2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - SMAD2
  - AKT1
  - AKT2
  - AKT3
  - SMAD3
  - SMAD4
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - CDKN1A
  - SLC12A9
  - dpp
  - gbb
  - put
  - mav
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Ras64B
  - Ras85D
  - Smox
  - Akt
  - Med
  - Dsor1
  - Mtk
  - Tor
  - Erk7
  - rl
  - bmp2a
  - bmp2b
  - tgfbr1a
  - tgfbr2b
  - pak2a
  - itpka
  - rab1ab
  - braf
  - si:dkey-222f8.3
  - smad2
  - smad3a
  - smad4a
  - smad4b
  - mtor
  - cdkn1a
  - BEZ235
  - Cancer
  - Cardiomyopathy
  - Lung cancer
---
